Cargando…
Synthesis, Structure Elucidation, Antibacterial Activities, and Synergistic Effects of Novel Juglone and Naphthazarin Derivatives Against Clinical Methicillin-Resistant Staphylococcus aureus Strains
Infections caused by drug-resistant bacteria are a serious threat to human and global public health. Moreover, in recent years, very few antibiotics have been discovered and developed by pharmaceutical companies. Therefore, there is an urgent need to discover and develop new antibacterial agents to...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640087/ https://www.ncbi.nlm.nih.gov/pubmed/34869221 http://dx.doi.org/10.3389/fchem.2021.773981 |
_version_ | 1784609264052994048 |
---|---|
author | Duvauchelle, Valentin Majdi, Chaimae Bénimélis, David Dunyach-Remy, Catherine Meffre, Patrick Benfodda, Zohra |
author_facet | Duvauchelle, Valentin Majdi, Chaimae Bénimélis, David Dunyach-Remy, Catherine Meffre, Patrick Benfodda, Zohra |
author_sort | Duvauchelle, Valentin |
collection | PubMed |
description | Infections caused by drug-resistant bacteria are a serious threat to human and global public health. Moreover, in recent years, very few antibiotics have been discovered and developed by pharmaceutical companies. Therefore, there is an urgent need to discover and develop new antibacterial agents to combat multidrug-resistant bacteria. In this study, two novel series of juglone/naphthazarin derivatives (43 compounds) were synthesized and evaluated for their antibacterial properties against various clinical and reference Gram-positive MSSA, clinical Gram-positive MRSA, and clinical and reference Gram-negative bacteria E. coli and P. aeruginosa. These strains are of clinical importance because they belong to ESKAPE pathogens. Compounds 3al, 5ag, and 3bg showed promising activity against clinical and reference MSSA (MIC: 1–8 µg/ml) and good efficacy against clinical MRSA (MIC: 2–8 µg/ml) strains. 5am and 3bm demonstrated better activity on both MSSA (MIC: 0.5 µg/ml) and MRSA (MIC: 2 µg/ml) strains. Their MICs were similar to those of cloxacillin against clinical MRSA strains. The synergistic effects of active compounds 3al, 5ag, 5am, 3bg, and 3bm were evaluated with reference antibiotics, and it was found that the antibiotic combination with 3bm efficiently enhanced the antimicrobial activity. Compound 3bm was found to restore the sensitivity of clinical MRSA to cloxacillin and enhanced the antibacterial activity of vancomycin when they were added together. In the presence of 3bm, the MIC values of vancomycin and cloxacillin were lowered up to 1/16th of the original MIC with an FIC index of 0.313. Moreover, compounds 3al, 5ag, 5am, 3bg, and 3bm did not present hemolytic activity on sheep red blood cells. In silico prediction of ADME profile parameter results for 3bm is promising and encouraging for further development. |
format | Online Article Text |
id | pubmed-8640087 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86400872021-12-04 Synthesis, Structure Elucidation, Antibacterial Activities, and Synergistic Effects of Novel Juglone and Naphthazarin Derivatives Against Clinical Methicillin-Resistant Staphylococcus aureus Strains Duvauchelle, Valentin Majdi, Chaimae Bénimélis, David Dunyach-Remy, Catherine Meffre, Patrick Benfodda, Zohra Front Chem Chemistry Infections caused by drug-resistant bacteria are a serious threat to human and global public health. Moreover, in recent years, very few antibiotics have been discovered and developed by pharmaceutical companies. Therefore, there is an urgent need to discover and develop new antibacterial agents to combat multidrug-resistant bacteria. In this study, two novel series of juglone/naphthazarin derivatives (43 compounds) were synthesized and evaluated for their antibacterial properties against various clinical and reference Gram-positive MSSA, clinical Gram-positive MRSA, and clinical and reference Gram-negative bacteria E. coli and P. aeruginosa. These strains are of clinical importance because they belong to ESKAPE pathogens. Compounds 3al, 5ag, and 3bg showed promising activity against clinical and reference MSSA (MIC: 1–8 µg/ml) and good efficacy against clinical MRSA (MIC: 2–8 µg/ml) strains. 5am and 3bm demonstrated better activity on both MSSA (MIC: 0.5 µg/ml) and MRSA (MIC: 2 µg/ml) strains. Their MICs were similar to those of cloxacillin against clinical MRSA strains. The synergistic effects of active compounds 3al, 5ag, 5am, 3bg, and 3bm were evaluated with reference antibiotics, and it was found that the antibiotic combination with 3bm efficiently enhanced the antimicrobial activity. Compound 3bm was found to restore the sensitivity of clinical MRSA to cloxacillin and enhanced the antibacterial activity of vancomycin when they were added together. In the presence of 3bm, the MIC values of vancomycin and cloxacillin were lowered up to 1/16th of the original MIC with an FIC index of 0.313. Moreover, compounds 3al, 5ag, 5am, 3bg, and 3bm did not present hemolytic activity on sheep red blood cells. In silico prediction of ADME profile parameter results for 3bm is promising and encouraging for further development. Frontiers Media S.A. 2021-11-19 /pmc/articles/PMC8640087/ /pubmed/34869221 http://dx.doi.org/10.3389/fchem.2021.773981 Text en Copyright © 2021 Duvauchelle, Majdi, Bénimélis, Dunyach-Rémy, Meffre and Benfodda. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Chemistry Duvauchelle, Valentin Majdi, Chaimae Bénimélis, David Dunyach-Remy, Catherine Meffre, Patrick Benfodda, Zohra Synthesis, Structure Elucidation, Antibacterial Activities, and Synergistic Effects of Novel Juglone and Naphthazarin Derivatives Against Clinical Methicillin-Resistant Staphylococcus aureus Strains |
title | Synthesis, Structure Elucidation, Antibacterial Activities, and Synergistic Effects of Novel Juglone and Naphthazarin Derivatives Against Clinical Methicillin-Resistant Staphylococcus aureus Strains |
title_full | Synthesis, Structure Elucidation, Antibacterial Activities, and Synergistic Effects of Novel Juglone and Naphthazarin Derivatives Against Clinical Methicillin-Resistant Staphylococcus aureus Strains |
title_fullStr | Synthesis, Structure Elucidation, Antibacterial Activities, and Synergistic Effects of Novel Juglone and Naphthazarin Derivatives Against Clinical Methicillin-Resistant Staphylococcus aureus Strains |
title_full_unstemmed | Synthesis, Structure Elucidation, Antibacterial Activities, and Synergistic Effects of Novel Juglone and Naphthazarin Derivatives Against Clinical Methicillin-Resistant Staphylococcus aureus Strains |
title_short | Synthesis, Structure Elucidation, Antibacterial Activities, and Synergistic Effects of Novel Juglone and Naphthazarin Derivatives Against Clinical Methicillin-Resistant Staphylococcus aureus Strains |
title_sort | synthesis, structure elucidation, antibacterial activities, and synergistic effects of novel juglone and naphthazarin derivatives against clinical methicillin-resistant staphylococcus aureus strains |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640087/ https://www.ncbi.nlm.nih.gov/pubmed/34869221 http://dx.doi.org/10.3389/fchem.2021.773981 |
work_keys_str_mv | AT duvauchellevalentin synthesisstructureelucidationantibacterialactivitiesandsynergisticeffectsofnoveljugloneandnaphthazarinderivativesagainstclinicalmethicillinresistantstaphylococcusaureusstrains AT majdichaimae synthesisstructureelucidationantibacterialactivitiesandsynergisticeffectsofnoveljugloneandnaphthazarinderivativesagainstclinicalmethicillinresistantstaphylococcusaureusstrains AT benimelisdavid synthesisstructureelucidationantibacterialactivitiesandsynergisticeffectsofnoveljugloneandnaphthazarinderivativesagainstclinicalmethicillinresistantstaphylococcusaureusstrains AT dunyachremycatherine synthesisstructureelucidationantibacterialactivitiesandsynergisticeffectsofnoveljugloneandnaphthazarinderivativesagainstclinicalmethicillinresistantstaphylococcusaureusstrains AT meffrepatrick synthesisstructureelucidationantibacterialactivitiesandsynergisticeffectsofnoveljugloneandnaphthazarinderivativesagainstclinicalmethicillinresistantstaphylococcusaureusstrains AT benfoddazohra synthesisstructureelucidationantibacterialactivitiesandsynergisticeffectsofnoveljugloneandnaphthazarinderivativesagainstclinicalmethicillinresistantstaphylococcusaureusstrains |